|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
West (WST) Introduces the NovaGuard(TM) Safety Needle System
7/28/2009 1:07:43 PM
West (NYSE: WST), the global leader in innovative solutions for injectable drug administration, has introduced the NovaGuard system, a passive safety needle compatible with Luer Lock syringes. The NovaGuard system, designed to help mitigate the risk of accidental needlestick injuries, is 510k-cleared by the U.S. Food and Drug Administration.
With the NovaGuard system, a plastic shield surrounds the needle before the injection is given, leaving only the needle tip exposed for injection site orientation. When the needle is pressed on the patient’s skin to administer the injection, the protective shield is activated. As the needle is withdrawn, the shield extends forward to cover the needle fully and the shield is locked in place. Unlike “active” needle safety devices, the NovaGuard system provides a safety feature without changing standard injection practices, and requires no extra steps to activate the safety feature.
“The innovative NovaGuard system provides the market with a truly passive safety needle system that can be attached by the user to a Luer Lock syringe,” said Graham Reynolds, Vice President, Innovation Strategic Marketing at West. “This product adds to West’s established solutions aimed at enhancing the safety, convenience and effectiveness of drug preparation and administration.”
Extensive field testing with nurses helped optimize the design of the NovaGuard system. These tests demonstrated the system’s intuitive, dependable and easy-to-use self-activated operation.
The NovaGuard system benefits health care practitioners, patients and pharmaceutical companies.
• For health care practitioners, the NovaGuard system is easy to use, without any change to drug administration technique. The NovaGuard system can also help reduce needlestick injuries and improve OSHA compliance.
• For patients, injections given with the NovaGuard system can be less threatening because the needle is covered throughout the procedure.
• For pharmaceutical companies, the NovaGuard system does not require any changes to their manufacturing processes and can help compliance with safety standards, such as those required by OSHA.
The Tech Group, a West company, manufactures the NovaGuard system at its facility in Montgomery, Pa.
A video demonstration of the NovaGuard system is available at WestNovaGuard.com.
About West
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.
NovaGuard™ is a trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
|
|
|
|
|
|
|
|
|
|
|